Combining baloxavir marboxil with standard-of-care neuraminidase inhibitor in patients hospitalised with severe influenza (FLAGSTONE): a randomised, parallel-group, double-blind, placebo-controlled, superiority trial

Population Pharmacokinetics and Exposure-Response Relationships of Baloxavir Marboxil in Patients Infected with Influenza at High Risk of Influenza Complications

(2020) Hiroki Koshimichi et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

DEVELOPMENT OF AN ORDINAL SCALE TREATMENT ENDPOINT IN ADULTS HOSPITALIZED WITH INFLUENZA

(2020) Nelson Lee et al.   CLINICAL INFECTIOUS DISEASES

Clinical outcomes of baloxavir versus oseltamivir in patients hospitalized with influenza A

(2020) Sunish Shah et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

A Phase 2 Study of Pimodivir (JNJ-63623872) in Combination With Oseltamivir in Elderly and Nonelderly Adults Hospitalized With Influenza A Infection: OPAL Study

(2020) Brian O’Neil et al.   JOURNAL OF INFECTIOUS DISEASES

Early treatment with baloxavir marboxil in high-risk adolescent and adult outpatients with uncomplicated influenza (CAPSTONE-2): a randomised, placebo-controlled, phase 3 trial

(2020) Michael G Ison et al.   LANCET INFECTIOUS DISEASES

Baloxavir Marboxil Single-dose Treatment in Influenza-infected Children

(2020) Jeffrey Baker et al.   PEDIATRIC INFECTIOUS DISEASE JOURNAL

Burden of influenza B virus infection and considerations for clinical management

(2020) Hassan Zaraket et al.   ANTIVIRAL RESEARCH

Oseltamivir plus usual care versus usual care for influenza-like illness in primary care: an open-label, pragmatic, randomised controlled trial

(2019) Christopher C Butler et al.   LANCET

Five years of monitoring for the emergence of oseltamivir resistance in patients with influenza A infections in the Influenza Resistance Information Study

(2018) Bruno Lina et al.   Influenza and Other Respiratory Viruses

Multicenter Evaluation of BioFire FilmArray Respiratory Panel 2 for Detection of Viruses and Bacteria in Nasopharyngeal Swab Samples

(2018) Amy L. Leber et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Baloxavir Marboxil for Uncomplicated Influenza in Adults and Adolescents

(2018) Frederick G. Hayden et al.   NEW ENGLAND JOURNAL OF MEDICINE

Clinical Practice Guidelines by the Infectious Diseases Society of America: 2018 Update on Diagnosis, Treatment, Chemoprophylaxis, and Institutional Outbreak Management of Seasonal Influenzaa

(2018) Timothy M Uyeki et al.   CLINICAL INFECTIOUS DISEASES

Combination treatment with the cap-dependent endonuclease inhibitor baloxavir marboxil and a neuraminidase inhibitor in a mouse model of influenza A virus infection

(2018) Keita Fukao et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Phase 2b Study of Pimodivir (JNJ-63623872) as Monotherapy or in Combination With Oseltamivir for Treatment of Acute Uncomplicated Seasonal Influenza A: TOPAZ Trial

(2018) Robert W Finberg et al.   JOURNAL OF INFECTIOUS DISEASES

Intravenous zanamivir or oral oseltamivir for hospitalised patients with influenza: an international, randomised, double-blind, double-dummy, phase 3 trial

(2017) Francisco M Marty et al.   Lancet Respiratory Medicine

Oseltamivir treatment for influenza in adults: a meta-analysis of randomised controlled trials

(2015) Joanna Dobson et al.   LANCET

Evaluation of Intravenous Peramivir for Treatment of Influenza in Hospitalized Patients

(2014) M. D. de Jong et al.   CLINICAL INFECTIOUS DISEASES

Detection of Nonhemagglutinating Influenza A(H3) Viruses by Enzyme-Linked Immunosorbent Assay in Quantitative Influenza Virus Culture

(2014) C. A. van Baalen et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Effectiveness of neuraminidase inhibitors in reducing mortality in patients admitted to hospital with influenza A H1N1pdm09 virus infection: a meta-analysis of individual participant data

(2014) Stella G Muthuri et al.   Lancet Respiratory Medicine

A clinical trial of intravenous peramivir compared with oral oseltamivir for the treatment of seasonal influenza in hospitalized adults

(2012) Michael G Ison et al.   ANTIVIRAL THERAPY

Diagnosis, management and outcomes of adults hospitalized with influenza

(2012) Nelson Lee et al.   ANTIVIRAL THERAPY

Treatment With Neuraminidase Inhibitors for Critically Ill Patients With Influenza A (H1N1)pdm09

(2012) J. K. Louie et al.   CLINICAL INFECTIOUS DISEASES

End Points for Testing Influenza Antiviral Treatments for Patients at High Risk of Severe and Life‐Threatening Disease

(2010) Michael G. Ison et al.   JOURNAL OF INFECTIOUS DISEASES

Clinical Management of Pandemic 2009 Influenza A(H1N1) Infection

(2009) David S. Hui et al.   CHEST